on the way to $1, page-16

First 16 Last

Share
Profile

Follow
AMreidIt

101 Posts.

26

04/06/18

14:45

Post #: 33478369
Share

Originally posted by 88888acct ↑

Hi Swift SX

In the near-term I would expect news on the following within the next 3-months ish (June-August):

1. Reagent Development (based on 14 May 2018 cloning is underway at which point this becomes nearly fully derisked and goes into pre-production steps of characterisation, small scale manufacturing and biobanking of the "blue-print"). To date this is trending ahead of the timelines indicated in the GANTT chart appearing in the prospectus and announcements.

2. IVD Kit Development and Production Transfer

3. Commencement of Study 6: Validation Study (comparison of clinical performance of old and new reagents before and making any adjustments before going into study 7).

4. Enrolment of study 7 Clinical Trial Sites and Potential for Early Patient Recruitment (I would expect given the previous interest by BUPA & the fact that colorectal cancer is the third largest cause of cancer related mortality that there may be some government support to accelerate commercialisation). (Source http://sprout8.com/rhy-research-report/)

The other obvious catalyst is general rerate following tightening of the capital structure, which we have seen - top 50 now exceed 70% and we've seen a highly successful small cap fund enter with 2.2% of the company (here's hoping they go substantial).

Bear in mind, out of the 100.75M shares on issue, 47.5M shares are escrowed..

And importantly, the valuation already trails less well progressed peers by a factor of 5x and statistically and cost inferior, Colvera (US$300 per test) by 10x (c. $200M valuation),.

Fundamentally the story remains one of the best I have found on the ASX in the best performing sector of 2018, globally (Health Care). However as we can all probably appreciate, where there are unrealistic expectations set and shares go into the wrong hands in the IPO, which is what RHY went through, there will be stag selling and overhang when those unrealistic expectations are not met.

Lots of blue sky from here IMO and I have used this as an opportunity to get my average to c. 0.18.

Cheers

5x8's

Expand

pursuant to coverage in attached tweet from Sprout8

looks like RHY has tightened up a lot over May!!!! stealth accumulators likely been keeping it under 20c but cannot last long. looks like it is ready to launch through 20c

especially with reagent dev finalisation getting closer, update expected sometime within June

once that gets ticked off, there should be rapid news flow relating to trials

get in soon...

RHY Price at posting: 19.0¢ Sentiment: Hold Disclosure: Held
5 Upvote

2 Great analysis

Reply

Top Stories

HXG

Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate

RBA holds rates as ALP election campaigning kicks off – expect more political focus

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

EBR

Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

There are more pages in this discussion • 20 more messages in this thread...

First 16 Last

Add RHY (ASX) to my watchlist

(20min delay)
Last 10.0¢		Change 0.000(0.00%)		Mkt cap ! $15.41M

Open	High	Low	Value	Volume
10.0¢	10.0¢	10.0¢	$5K	50K

Buyers (Bids)

No.	Vol.	Price($)
2	55913	10.0¢

Sellers (Offers)

Price($)	Vol.	No.
10.5¢	18707	1

View Market Depth

No.	Vol.	Price($)
2	75525	0.063
1	16000	0.062
2	83639	0.060
2	38605	0.051
1	66665	0.045

Price($)	Vol.	No.
0.064	9245	1
0.065	51999	3
0.066	107305	1
0.067	195346	2
0.070	1794	1

Last trade - 10.08am 05/11/2024 (20 minute delay)

RHY (ASX) Chart

on the way to $1, page-16

Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate

RBA holds rates as ALP election campaigning kicks off – expect more political focus

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

on the way to $1, page-16

Top Stories

Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate

RBA holds rates as ALP election campaigning kicks off – expect more political focus

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News